News

AAN 2023: Muscle symptoms not always caused by granulomas

Only about half of sarcoidosis patients showing signs of muscle disease, or myopathy, have the small clumps of immune cells in their muscles that characterize sarcoidosis, a study showed. When these clumps, called granulomas, weren’t present with muscle symptoms, myopathy was most often linked to inclusion body myositis (IBM),…

Sarcoidosis-associated lung bleeding may be more common than known

A lung bleeding condition called diffuse alveolar hemorrhage (DAH) may develop secondary to sarcoidosis more frequently than previously reported, a small study suggests. Considering the frequency of DAH associated with sarcoidosis reported in the study, “it is essential to consider sarcoidosis in the differential diagnosis of immune-mediated DAH,” the researchers…

This Sarcoidosis Awareness Month ‘Stand Up for Sarc’

The Foundation for Sarcoidosis Research (FSR) is offering ways to participate in National Sarcoidosis Awareness Month, observed each April, to call attention to sarcoidosis and the 175,000 U.S. residents thought to be living with the disease. Despite advances in research, sarcoidosis remains challenging to diagnose and…

Earlier moves to specialist, better therapies welcome, patients say

People with pulmonary sarcoidosis believe earlier referrals to specialists could improve the diagnostic process and call for new treatment approaches leading to a better quality of life, according to findings from a discussion with patients from six countries. They also questioned the “concept of remission” in a multiorgan disease…

FSR’s Inaugural Sarcoidosis Crystal Awards Gala set for May 24

Four sarcoidosis patients and researchers who work to better understand the disease and raise awareness about it will be honored at the Foundation for Sarcoidosis Research (FSR)’s Inaugural Sarcoidosis Crystal Awards Gala  Celebrating Connections, Collaboration, and Catalyzing Research. The gala, which will take place May 24 from 6…

LAS system may not reflect risks for lung transplant patients

The Lung Allocation Score (LAS) system, which is used to prioritize patients awaiting lung transplant, may not accurately reflect disease severity risks for people with pulmonary sarcoidosis, a new study reports. Results showed that several factors accounted for in the LAS remain significant predictors of mortality for patients on…